Molecular Therapy is the leading research journal in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2019 impact factor is 8.986.
The Molecular Therapy family of journals includes:
- Methods & Clinical Development
- Nucleic Acids
ASGCT members receive an online subscription with full access to content within the Molecular Therapy Family of Journals. Full and transitional members receive publication discounts of $700 for open access articles or $52 per page. Learn more